Methyldopate Hydrochloride (American Regent, Inc.)


Welcome to the PulseAid listing for the Methyldopate Hydrochloride drug offered from American Regent, Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Methyldopate Hydrochloride
SUBSTANCE NAME: METHYLDOPATE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1995-09-30
END MARKETING DATE: 0000-00-00


Methyldopate Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethyldopate Hydrochloride from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 1995-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-8905_2627d4f7-5db1-49e0-bf19-0027ab27197b
PRODUCT NDC: 0517-8905
APPLICATION NUMBER: ANDA071279

Other METHYLDOPATE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Methyldopate Hydrochloride